Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ji-Min Shi"'
Autor:
Ting-Ting Yang, Ye Meng, De-Lin Kong, Guo-Qing Wei, Ming-Ming Zhang, Wen-Jun Wu, Ji-Min Shi, Yi Luo, Yan-Min Zhao, Jian Yu, Rui-Rui Jing, Meng-Yu Zhao, Hou-Li Zhao, He Huang, Yong-Xian Hu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionChimeric antigen receptor (CAR) T-cell (CAR-T) therapy followed by haploidentical hematopoietic stem cell transplantation (haplo-HSCT) markedly improves the long-term survival of patients with refractory/relapsed (R/R) B-cell acute lympho
Externí odkaz:
https://doaj.org/article/d2dade5d80084fd29b673875840c94b1
Autor:
Hua-Rui Fu, Ting-Ting Yang, Yan-Min Zhao, Ya-Min Tan, Qi-Qi Gao, He Huang, Ji-Min Shi, Peng Lyu
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 22, Pp 2756-2758 (2021)
Externí odkaz:
https://doaj.org/article/4448c0d967604b4db42362b2a35eebc9
Autor:
Ting-Ting Yang, Xue-Ping Luo, Qing Yang, Hong-Chao Chen, Yi Luo, Yan-Min Zhao, Yi-Shan Ye, Xiao-Yu Lai, Jian Yu, Ya-Min Tan, Guo-Qing Wei, He Huang, Ji-Min Shi
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-9 (2020)
Abstract Background A consensus has been reached that carbapenem-resistant Enterobacteriaceae (CRE) screening in immunosuppressed individuals can reduce the incidence of CRE bloodstream infection (BSI). Methods We retrospectively studied the clinical
Externí odkaz:
https://doaj.org/article/c14690474b184188ad19008106f91f0b
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Posttransplant lymphoproliferative disorder (PTLD) is a rare complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) with poor prognosis. We report a patient with PTLD involved central nervous system (CNS) who treated with z
Externí odkaz:
https://doaj.org/article/8db065df053c43e8b368d61e93b01285
Autor:
Ting-Ting, Yang, Xiao-Lu, Song, Yan-Min, Zhao, Bao-Dong, Ye, Yi, Luo, Hao-Wen, Xiao, Yi, Chen, Hua-Rui, Fu, Jian, Yu, Li-Zhen, Liu, Xiao-Yu, Lai, Yi-Shan, Ye, Jian-Ping, Lan, He, Huang, Ji-Min, Shi
Publikováno v:
Annals of Hematology. 101:2731-2741
The use of Bcl-2 inhibitor Venetoclax (VEN) combined with hypomethylating agents or chemotherapy has shown efficacy in treating acute myeloid leukemia (AML) as frontline treatment and for relapse, allowing more patients to bridge to allogeneic hemato
Autor:
Xiao-Lin Yuan, Xiao-Yu Lai, Yi-Bo Wu, Lu-Xin Yang, Ji-Min Shi, Li-Zhen Liu, Jian Yu, Yan-Min Zhao, Wei-Yan Zheng, Jing-Song He, Jie Sun, Wen-Jun Wu, Yi Zhao, Yi-Shan Ye, Zhen Cai, He Huang, Yi Luo
Publikováno v:
Bone Marrow Transplantation.
Autor:
Ying‐Ying Ma, Ze‐liang Wei, Ya‐Jing Xu, Ji‐Min Shi, Hai Yi, Yong‐Rong Lai, Er‐Lie Jiang, San‐Bin Wang, Tao Wu, Lei Gao, Li Gao, Pei‐Yan Kong, Qin Wen, Hai Bai, Yu Li, Yi‐geng Cao, Qiao‐Chuan Li, Zhong‐Ming Zhang, Bei‐Cai Liu, Yi Su, Xiao‐Yu Lai, Xia Ma, Ting‐Ting Cheng, Yi Luo, Xi Zhang, Cheng Zhang
Publikováno v:
Cancer.
Autor:
Ying-Ying Ma, Ze-Liang Wei, Ya-Jing Xu, Ji-Min Shi, Hai Yi, Rong-Yong Lai, Er-Lie Jiang, San-Bin Wang, Tao Wu, Lei Gao, Li Gao, Pei-Yan Kong, Qin Wen, Hai Bai, Yu Li, Yi-geng Cao, Qiao-Chuan Li, Zhong-Ming Zhang, Bei-Cai Liu, Yi Su, Xiao-Yu Lai, Xia Ma, Ting-Ting Cheng, Yi Luo, Xi Zhang, Cheng Zhang
Publikováno v:
SSRN Electronic Journal.
Autor:
Ting-Ting Yang, Ye Meng, De-Lin Kong, Guo-Qing Wei, Ming-Ming Zhang, Wen-Jun Wu, Ji-Min Shi, Yi Luo, Yan-Min Zhao, Jian Yu, Rui-Rui Jing, Meng-Yu Zhao, Hou-Li Zhao, He Huang, Yong-Xian Hu
Publikováno v:
Frontiers in Immunology; 8/30/2022, Vol. 13, p1-13, 13p
Autor:
Xiao-Lin, Yuan, Ya-Min, Tan, Ji-Min, Shi, Yan-Min, Zhao, Jian, Yu, Xiao-Yu, Lai, Lu-Xin, Yang, He, Huang, Yi, Luo
Publikováno v:
Annals of hematology. 100(2)
Minimal residual disease (MRD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) heralds high risk of relapse. Whether preemptive recombinant interleukin-2 (pre-IL2) is effective for patients with late-onset MRD (LMRD) remains unkn